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Objectives: Inhibition of the renin-angiotensin system (RAS) has lead to important
pharmacological tools to treat atherosclerosis and other cardiovascular diseases.
Angiotensin-converting enzyme 2 (ACE2) has emerged as a central negative regulator
of RAS by degrading angiotensin (Ang) II to generate Ang-(1-7). We hypothesized
that ACE2 would exert beneﬁcial effects on myocardial injury in apolipoprotein
E-knockout (ApoEKO; ApoE-/-) mice.
Methods: In this work, we used 3-month-old wild-type, ApoEKO, and ACE2/ApoE
double-KO mice. We implanted subcutaneously mini-osmotic pumps with Ang II
(1.5 mg/kg/d) or saline for 2 weeks in the ApoE-/- mice which were then treated with
recombinant human ACE2 (hrACE2; 2 mg/kg/d). We characterized the functional,
structural and molecular changes in mice hearts.
Results: Compared with the ApoE-/- mice, ACE2 deﬁciency triggered greater in-
creases in cardiac expression of CTGF and phosphorylated level of pERK1/2 in the
ACE2/ApoE double-KO mice (n¼5-6; P<0.01, respectively). These changes were
associated with exacerbation of myocardial ultrastructure injury and greater activation
of inﬂammatory factors including CCL2, fractalkine (FKN), interleukin 1b (IL1b),
IL17, and ICAM1. Ang II infusion resulted in a predicted pressor response and
marked increases in cardiac expression of CCL2, FKN, IL1b, IL17, and ICAM1 in the
ApoE-/- mice with activation of the CTGF and ERK signaling (n¼5-6; P<0.05 or
P<0.01, respectively). Consistent with induction of inﬂammation, Ang II infusion led
to elevation of superoxide production and severe ultrastructure injury in hearts of the
ApoE-/- mice with increased cardiac NADPH oxidase activity and elevated circulating
Ang II levels. Notably, treatment with hrACE2 strikingly alleviated oxidative stress
and attenuated ultrastructure injury in the hearts of Ang II-treated ApoE-/- mice linked
with reduction of NADPH oxidase activity and abolishment of expression of CTGF,
P-ERK1/2, CCL2, ICAM1, FKN, IL1b and IL17 (n¼4-5; P<0.05 or P<0.01,
respectively). However, there were no changes in p38-MAPK and CX3CR1 levels
among groups (n¼4-6; P>0.05; respectively).
Conclusions: Absence of ACE2 triggers greater increases in myocardial inﬂammation
and oxidative stress in the ACE2/ApoE double-mutant mice with exacerbation of
myocardial ultrastructure injury. Conversely, ACE2 overexpression alleviates Ang II-
mediated inﬂammation and ultrastructure injury in hearts of the ApoE-deﬁcient mice
with suppression of superoxide generation and the CTGF-ERK signaling activation.
Strategies aimed at enhancing ACE2 action may have important therapeutic potential
for cardiac disorders.
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Objectives: Diastolic heart failure (DHF) patients had higher left ventricular (LV)
stiffness, optimal therapy for DHF has not been determined. The efﬁciency of the
angiotensin receptor blocker (ARB) on DHF treatment has been controversy.
Accordingly, this preliminary study was to investigate the effect of the different doses
of candesartan on the early DHF to prevent passive LV stiffness in diabetic rabbits.
Methods: Sixty rabbits were randomly divided into 4 groups (n¼15 in each group).
Group 1 (G1) and Group 2 (G2) were assigned to the following candesartan cilexetil
(G1: 1mg/kg/d and G2: 5mg/kg/d) treatment on the 4th day after injection of alloxan
of a 4-wk pacing schedule. The other rabbits were assigned to the diabetic group (GD,
no medicine treatment of alloxan injection) and control group (GC, normal rabbits).
LV function was measured by echocardiography. LV passive stiffness was evaluated
by cardiac morphology, myocardial deposition of collagen and advanced glycationJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/Bend products (AGEs) through electron microscopy, HE staining method, Immuno-
histochemical method, and Quantitative histomorphometry. Cardiac total titin and titin
N2B/N2BA ratio were measured by gel electrophoresis, and total titin mRNA level
expression was assessed by Quantitative real-time PCR.
Results: All the diabetic rabbits were identiﬁed that LV diastolic dysfunction with
preserved systolic function measured by echocardiography through 4 weeks. Collagen
solubility percentage (%) (G1, 46.083.05; G2, 48.543.04; GD, 40.432.75 vs.
GC, 50.222.99; P<0.05), Immunohistochemistry CML scoring (score/mm2) (G1,
29.524.22; G2, 24.82.97; GD, 40.893.01 vs. GC, 15.591.88; P<0.05) and the
expression of titin mRNA (G1, 4.580.47; G2, 5.150.63; GD, 3.550.58 vs. GC,
10.2; P<0.05) were differ signiﬁcantly among these four groups, but there were not
differ signiﬁcantly between G1 and G2 (P>0.05), however, differ signiﬁcantly
between ARB treatment groups and diabetic group in the Immunohistochemistry
CML scoring. In all diabetic rabbits, there was not investigated of interstitial ﬁbrosis
by Masson’s trichrome stain. Total titin amount and N2B/N2BA ratio by method of
Quantitative protein analysis were no differences between all the groups.
Conclusions: ARB therapy which is independent of its dosage tailored to reducing the
deleterious effects of the CML-AGEs deposited in diabetic cardiomyopathy of early
stage was being experiment and providing evidences of possible underlying mecha-
nisms of DHF.
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Objectives: The Golgi SNAP Receptor Complex Member 2 (GOSR2) gene is Golgi-
associated soluble factor attachment receptor (SNARE) protein. Some SNPs in
GOSR2 gene are found to be associated with coronary artery disease (CAD) and
myocardial infarction (MI). The aim of the present study was to assess the association
between the human GOSR2 gene and coronary artery disease using a haplotype-based
case-control study in Chinese Han population.
Methods: A total of 283 CAD patients and 280 controls were genotyped for the ﬁve
single-nucleotide polymorphisms (SNPs) used as genetic markers for the human
GOSR2 gene (rs197932, rs3785889, rs197922, rs17608766, and rs16941382). Data
were analyzed for three separate groups: the total subjects, men, and women.
Results: In the recessive model of re197932 in men, there was statistical difference in
CC genotype and TT+CT genotypes distribution between CAD and control group. In
total subjects, the overall distribution of the haplotypes established by rs3785889-
rs16941382 was signiﬁcantly different between the CAD patients and the control
subjects. For the total subjects, the frequency of the G-T haplotype established by
rs3785889-rs16941382 was signiﬁcantly higher for the CAD patients as compared to
the control subjects (P¼0.009). Multiple logistic regression analysis also revealed that
the people with G-T haplotype established by rs3785889-rs16941382 (homozygote)
were found to have signiﬁcantly higher chance of suffering from CAD than the ones
without this haplotype after adjustment for the major risk factors (OR¼1.887,
P¼0.007).
Conclusions: The results of this study indicate that the G-T haplotype established by
rs3785889-rs16941382 may be a useful genetic marker for CAD patients in Chinese
Han population.
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Objectives: To investigate the effects of Angiotensin-(1-7) [Ang-(1-7)] signaling
pathway on atrial electrical remodeling in rapid atrial pacing canine model and the
possible role of atrial natriuretic peptide (ANP).
Methods: Thirty-ﬁve dogs were assigned to seven groups randomly. There are sham
group, paced control group, paced + Ang-(1-7) group, paced + Ang-(1-7) + A-779
group, paced + Ang-(1-7) + API-2 group, paced + Ang-(1-7) + wortmannin group,
and paced + Ang-(1-7) + L-NAME group, 5 dogs in each group. Rapid atrial pacing at
600 bpm was maintained for 2 hours except the animals from the sham group. During
the pacing, Ang-(1-7) (6mg$kg-1$h-1), A-779 (Mas inhibitor, 5.83mg$kg-1$h-1), API-2
(Akt inhibitor, 2.14mg$kg-1$h1), wortmannin (PI3K inhibitor, 2.86mg$kg-1$h-1) or
L-NAME (NO synthase inhibitor, 180mg$kg-1$h-1) were given intravenously, res-
pectively. Electrophysiological parameters including atrial effective refractory periods
(ERPs), inducibility and duration of atrial ﬁbrillation (AF) under different basic pacing
cycle length (300, 250, and 200 ms) were measured. Following electrophysiological
study, ANP concentration of the left atrium was detected.
Results: After atrial pacing for 2 hours, the atrial ERPs at 6 sites were shortened with
the increase in inducibility and duration of AF in paced control group (P<0.05, vs
sham). ANP concentration of the left atrium also increased in paced control group
(P<0.05, vs sham). The shortening of atrial ERPs, and the increasing of inducibility
and duration of AF induced by atrial pacing were attenuated by Ang-(1-7) treatment.asic and Translational Medicine C1
